Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

Completed · Phase 1

Conditions studied: Healthy Volunteer Study

In brief

Mass balance study of AT-527 in Healthy Male Subjects.

Key facts

Study ID

NCT05004415

Run by

Atea Pharmaceuticals, Inc.

People needed

6

Starts

2021-07-28

Expected to finish

2021-08-12

Last updated by the study team

2022-02-25

Who can join

Age: 19 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Minimum body weight of 50 kg and body mass index (BMI) of 18-32 kg/m2
• No clinically significant diseases captured in the medical history or clinically significant findings at screening physical examination.
• A non-vasectomized, male subject must agree to use a condom with spermicide or abstain from sexual intercourse during the study until 90 days after dosing. (No restrictions are required for a vasectomized male provided his vasectomy has been performed 4 months or more prior to dosing. A male who has been vasectomized less than 4 months prior to dosing must follow the same restrictions as a non-vasectomized male).
• Willing to comply with the study requirements and to provide written informed consent

You may not qualify if…

• Infected with hepatitis B virus, hepatitis C virus, HIV or COVID-19
• Abuse of alcohol or drugs
• Use of other investigational drugs within 28 days of dosing
• Other clinically significant medical conditions or laboratory abnormalities

Where it is running

• Atea Study Site — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.